Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Clinical Gastroenterology|October 21, 2011
Olanzapine and benztropine as a cause of ischemic colitis in a 27-year-old manStephen J Park, Nadege Gunn, Stephen A Harrison
Journal of Clinical and Translational Hepatology|July 22, 2026
Reducing the Risk of Overt Hepatic Encephalopathy Recurrence: A Narrative ReviewNikolaos T Pyrsopoulos, Nadege Gunn, Prasun K Jalal, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 3, 2023
The use of current knowledge and non-invasive testing modalities for predicting at-risk non-alcoholic steatohepatitis and assessing fibrosisMarcelo Kugelmas, Mazen Noureddin, Nadege Gunn, et al.
Diagnostics (Basel, Switzerland)|November 11, 2022
Accuracy of Noninvasive Diagnostic Tests for the Detection of Significant and Advanced Fibrosis Stages in Nonalcoholic Fatty Liver Disease: A Systematic Literature Review of the US StudiesDhaval Gosalia, Vlad Ratziu, Filip Stanicic, et al.
Nature Communications|September 18, 2021
A phase 2, proof of concept, randomised controlled trial of berberine ursodeoxycholate in patients with presumed non-alcoholic steatohepatitis and type 2 diabetesStephen A Harrison, Nadege Gunn, Guy W Neff, et al.
Clinical and Molecular Hepatology|April 21, 2025
HTD1801 Demonstrates Promising Potential for Histologic Improvements in MASH in Both a Preclinical and Phase 2 StudyVincent Wai-Sun Wong, Guy W Neff, Adrian M Di Bisceglie, et al.
The American Journal of Gastroenterology|November 3, 2022
A Randomized, Dose-Finding, Proof-of-Concept Study of Berberine Ursodeoxycholate in Patients With Primary Sclerosing CholangitisKris V Kowdley, Lisa Forman, Bertus Eksteen, et al.
Hepatology Communications|July 19, 2021
Improvements of Fibrosis and Disease Activity Are Associated With Improvement of Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic SteatohepatitisZobair M Younossi, Maria Stepanova, Mazen Noureddin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 23, 2023
Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Stage 3 Fibrosis (FALCON 1): A Randomized Phase 2b StudyRohit Loomba, Arun J Sanyal, Atsushi Nakajima, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 23, 2023
Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Compensated Cirrhosis (FALCON 2): A Randomized Phase 2b StudyManal F Abdelmalek, Arun J Sanyal, Atsushi Nakajima, et al.
Pageof 2